Pharmadrug Inc.
PHRX
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.63% | 53.25% | 98.40% | 97.48% | 97.10% |
| Total Depreciation and Amortization | 0.00% | -1.91% | -23.40% | -4.50% | 26.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.64% | -51.38% | -99.14% | -98.34% | -97.75% |
| Change in Net Operating Assets | 121.34% | 132.33% | 84.34% | 94.90% | -284.07% |
| Cash from Operations | 40.60% | 88.73% | 90.93% | 92.20% | 80.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -4,200.00% | -248.28% | -125.29% |
| Cash from Investing | -- | -- | -101.58% | -101.56% | -101.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 270.65% | -64.97% | -63.98% |
| Cash from Financing | 2,231.25% | -- | -101.57% | -100.75% | -100.64% |
| Foreign Exchange rate Adjustments | -- | -- | -383.33% | -230.77% | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.05% | 80.94% | -248.33% | -186.74% | -172.99% |